‌

US Patent 10036040 Methods and compositions for the activation of gamma-delta T-cells

Patent 10036040 was granted and assigned to American Gene Technologies on July, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

American Gene Technologies

Current Assignee

American Gene Technologies

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

July 31, 2018

Patent Application Number

15849062

Date Filed

December 20, 2017

Patent Citations Received

US Patent 12090200 Methods of producing cells resistant to HIV infection

0

US Patent 11911458 HIV pre-immunization and immunotherapy

0

US Patent 11976292 Non-integrating viral delivery system and methods related thereto

0

US Patent 11980663 HIV pre-immunization and immunotherapy

0

US Patent 10137144 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10233464 HIV pre-immunization and immunotherapy

US Patent 11519006 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10420789 Methods and compositions for the activation of gamma-delta T-cells

...

Patent Primary Examiner

Patent abstract

The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10036040 Methods and compositions for the activation of gamma-delta T-cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.